| Lori Renee Diseati, MD | |
|
39th Medical Group, Unit 7095, Apo, AE 09824-5185 | |
| (202) 714-4234 | |
| Not Available |
| Full Name | Lori Renee Diseati |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 39th Medical Group, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578530374 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Lori Renee Diseati, MD 39th Medical Group, Unit 7095, Apo, AE 09824-5185 Ph: (202) 714-4234 | Lori Renee Diseati, MD 39th Medical Group, Unit 7095, Apo, AE 09824-5185 Ph: (202) 714-4234 |
News Archive
Misonix, Inc., a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new, three year, exclusive distribution agreement with Instrumentacion, S.A. based in Bogota, Colombia.
The world's largest ever study into the impact and scalability of arts interventions on physical and mental health has been launched today by King's College London and UCL, supported by a £2m award from Wellcome Trust.
Researchers at Harvard Medical School (HMS) and Massachusetts General Hospital (MGH) have discovered a new cancer-promoting role for a gene potentially involved in breast, liver, and other kinds of cancers.
Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Private-Payer Profits Can Induce Negative Medicare Margins - "Hospitals' profit margins on privately insured patients have risen dramatically in recent years, while profit margins on Medicare patients have fallen," write the authors, who all work for MedPAC.
› Verified 4 days ago
Dr. Talitha Moon, DO, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: Sudlager 301, Apo, AE 92249 Phone: 314-590-2402 | |
Dr. Timothy D. Robinette, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86th Mdg Unit 3215, Apo, AE 09094 Phone: 314-480-4675 | |
John William Kieffer, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2273 | |
Dr. Donald Walter Robinson, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Hhc, Asg-ku, Attn: Medical, Apo, AE 09366 Phone: 706-239-9678 | |
Dr. Jeffrey Michael Diffenderfer, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-542-3080 | |
Dr. Sonia Leigh Molchan, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2609 | |
Dr. Admirado Adolfo Luzuriaga, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 004-963-71462609 |